BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9212921)

  • 1. Antisense transforming growth factor-beta 1 in wound healing.
    Chung HT; Choi BM; Jun CD; Park SD; Rim JS
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):257-61. PubMed ID: 9212921
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides.
    Choi BM; Kwak HJ; Jun CD; Park SD; Kim KY; Kim HR; Chung HT
    Immunol Cell Biol; 1996 Apr; 74(2):144-50. PubMed ID: 8724001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of wound-induced expression of transforming growth factor-beta 1 mRNA by its antisense oligonucleotides.
    Kim HM; Choi DH; Lee YM
    Pharmacol Res; 1998 Apr; 37(4):289-93. PubMed ID: 9634645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The experimental study on antisense TGF-beta 1 in inhibiting scar formation in III degree burn wound].
    Luo X; Zhao H; Zhang Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 Mar; 18(2):89-91. PubMed ID: 12192769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro.
    Riedel K; Riedel F; Goessler UR; Germann G; Sauerbier M
    Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of inducible nitric oxide synthase and its corresponding tetrahydrobiopterin-cofactor-synthesizing enzyme GTP-cyclohydrolase I during cutaneous wound repair.
    Frank S; Madlener M; Pfeilschifter J; Werner S
    J Invest Dermatol; 1998 Dec; 111(6):1058-64. PubMed ID: 9856817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transforming growth factor-beta 2 expression with phosphorothioate antisense oligonucleotides in U937 cells.
    Shen ZJ; Kim SK; Lee YS; Lee JW; Moon BJ
    Bioorg Med Chem Lett; 1999 Jan; 9(1):13-8. PubMed ID: 9990448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo.
    Sisco M; Kryger ZB; O'Shaughnessy KD; Kim PS; Schultz GS; Ding XZ; Roy NK; Dean NM; Mustoe TA
    Wound Repair Regen; 2008; 16(5):661-73. PubMed ID: 19128261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.
    Cordeiro MF; Mead A; Ali RR; Alexander RA; Murray S; Chen C; York-Defalco C; Dean NM; Schultz GS; Khaw PT
    Gene Ther; 2003 Jan; 10(1):59-71. PubMed ID: 12525838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta antisense oligonucleotides modulate expression of matrix metalloproteinases in isolated fibroblasts from radiated skin.
    Riedel K; Kremer T; Ryssel H; Riedel F; Goessler UR; Koellensperger E; Germann G; Sauerbier M
    In Vivo; 2008; 22(1):1-7. PubMed ID: 18396774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts.
    Rolfe KJ; Irvine LM; Grobbelaar AO; Linge C
    Wound Repair Regen; 2007; 15(6):897-906. PubMed ID: 18028139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of incisional wound healing in inducible nitric oxide synthase knockout mice.
    Most D; Efron DT; Shi HP; Tantry US; Barbul A
    Surgery; 2002 Nov; 132(5):866-76. PubMed ID: 12464872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro.
    Yokozeki M; Moriyama K; Shimokawa H; Kuroda T
    Exp Cell Res; 1997 Mar; 231(2):328-36. PubMed ID: 9087174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
    Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
    Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta and wound healing.
    Amento EP; Beck LS
    Ciba Found Symp; 1991; 157():115-23; discussion 123-9. PubMed ID: 2070681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes.
    Boissel JP; Ohly D; Bros M; Gödtel-Armbrust U; Förstermann U; Frank S
    J Invest Dermatol; 2004 Jul; 123(1):132-9. PubMed ID: 15191553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta s and wound healing.
    O'Kane S; Ferguson MW
    Int J Biochem Cell Biol; 1997 Jan; 29(1):63-78. PubMed ID: 9076942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-regulated gene expression during cutaneous wound repair.
    Beer HD; Fässler R; Werner S
    Vitam Horm; 2000; 59():217-39. PubMed ID: 10714241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages.
    Jun CD; Choi BM; Kim SU; Lee SY; Kim HM; Chung HT
    Immunology; 1995 May; 85(1):114-9. PubMed ID: 7635512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of therapeutic oligonucleotides.
    Diasio RB; Zhang R
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):239-43. PubMed ID: 9212918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.